🇺🇸 FDA

Intelligence · Patent portfolio

RIGEL PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for RIGEL PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
373
Expiring ≤24m
18

Quick answer

RIGEL PHARMACEUTICALS has 373 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 18 expire within 24 months — use filters for patent-cliff planning.

Page 6 of 8

  1. US 8377945

    Small molecule inhibitors of spleen tyrosine kinase (SYK)

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8377924

    Protein kinase C inhibitors and uses thereof

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8372415

    Wet granulation using a water sequestering agent

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8362235

    Carboxamide compounds and methods for using the same

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8349838

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8343954

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8334297

    2,4-pyrimidinediamine compounds for treatment of inflammatory disorders

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8334296

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8324200

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8314107

    Carboxamide compounds and methods for using the same

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8314093

    2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8309566

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8304422

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8299087

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8288382

    Diaminothiazoles useful as Axl inhibitors

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8278299

    Pyrimidinediamine kinase inhibitors

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8268851

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8263122

    Wet granulation using a water sequestering agent

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8246984

    Formulation of insoluble small molecule therapeutics in lipid-based carriers

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8227455

    Methods of treating cell proliferative disorders

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8211889

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8211888

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8193197

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8193181

    Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8188276

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8178671

    Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8168636

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8163902

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8158621

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8148525

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8129390

    Carboxamide, sulfonamide and amine compounds and methods for using the same

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8119809

    AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8101627

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8097630

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8053434

    Kinase inhibitors and their uses

    Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8044054

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8030483

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8012965

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8012955

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8008501

    Quinoline compounds and their uses

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7989448

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7947698

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7935693

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7915273

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7906644

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7884119

    Triazole derivatives useful as Axl inhibitors

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7884111

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7879856

    Diaminothiazoles useful as Axl inhibitors

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does RIGEL PHARMACEUTICALS have?

373 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RIGEL PHARMACEUTICALS patents expire?

18 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.